Where's it on?
FDA · Drugs ·

Daptomycin recall

Baxter Healthcare Corporation recalled Daptomycin on September 9, 2026 because of cGMP Deviations. It was sold nationwide.

Why it was recalled

CGMP Deviations

What's recalled

Daptomycin, in 0.9% Sodium Chloride Injection, 1,000 mg per 100 mL (10 mg/mL), 1,000 mg total, in 1000 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0718-12.

Quantity: N/A

What to do

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Read the official FDA notice